Stereotaxis Valuation
| STXS Stock | USD 2.32 0.06 2.52% |
Based on Macroaxis valuation methodology, the company appears to be overvalued. Stereotaxis has a current Real Value of $1.89 per share. The regular price of the company is $2.32. Our model measures the value of Stereotaxis from inspecting the company fundamentals such as Return On Equity of -1.8, operating margin of (0.79) %, and Shares Outstanding of 86 M as well as reviewing its technical indicators and probability of bankruptcy.
Overvalued
Today
Please note that Stereotaxis' price fluctuation is very risky at this time. Calculation of the real value of Stereotaxis is based on 3 months time horizon. Increasing Stereotaxis' time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the Stereotaxis stock is determined by what a typical buyer is willing to pay for full or partial control of Stereotaxis. Since Stereotaxis is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Stereotaxis Stock. However, Stereotaxis' intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 2.32 | Real 1.89 | Hype 2.32 | Naive 2.47 |
The intrinsic value of Stereotaxis' stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Stereotaxis' stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Stereotaxis helps investors to forecast how Stereotaxis stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Stereotaxis more accurately as focusing exclusively on Stereotaxis' fundamentals will not take into account other important factors: Stereotaxis Total Value Analysis
Stereotaxis is at this time anticipated to have valuation of 195.78 M with market capitalization of 204.68 M, debt of 6.01 M, and cash on hands of 30.94 M. Please note that valuation may be misleading and is a subject to auditing or accounting errors. We encourage investors to vigilantly validate all of the Stereotaxis fundamentals before making equity appraisal based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
195.78 M | 204.68 M | 6.01 M | 30.94 M |
Stereotaxis Investor Information
About 31.0% of the company outstanding shares are owned by corporate insiders. The company recorded a loss per share of 0.31. Stereotaxis had not issued any dividends in recent years. The entity had 1096:1000 split on the 4th of November 2013. Based on the key indicators related to Stereotaxis' liquidity, profitability, solvency, and operating efficiency, Stereotaxis is not in a good financial situation at this time. It has a very high probability of going through financial hardship in August.Stereotaxis Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Stereotaxis has an asset utilization ratio of 57.61 percent. This implies that the Company is making $0.58 for each dollar of assets. An increasing asset utilization means that Stereotaxis is more efficient with each dollar of assets it utilizes for everyday operations.Stereotaxis Ownership Allocation
Stereotaxis shows a total of 86 Million outstanding shares. Stereotaxis maintains significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Please note that no matter how many assets the company owns, if the real value of the company is less than the current market value, you may not be able to make money on it.Stereotaxis Profitability Analysis
The company reported the previous year's revenue of 26.92 M. Net Loss for the year was (24.05 M) with profit before overhead, payroll, taxes, and interest of 14.69 M.About Stereotaxis Valuation
The stock valuation mechanism determines Stereotaxis' current worth on a daily basis. In general, an absolute valuation approach attempts to find the value of Stereotaxis based exclusively on its fundamental and basic technical indicators. As compared to an absolute model, our relative valuation model uses a comparative analysis of Stereotaxis. We calculate exposure to Stereotaxis's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Stereotaxis's related companies.Stereotaxis, Inc. designs, manufactures, and markets robotic systems, instruments, and information systems for the interventional laboratory in the United States and internationally. Stereotaxis, Inc. was incorporated in 1990 and is headquartered in Saint Louis, Missouri. Stereotaxis operates under Medical Instruments Supplies classification in the United States and is traded on AMEX Exchange. It employs 130 people.
Stereotaxis Growth Indicators
Investing in growth stocks can be very risky. If the company such as Stereotaxis does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
| Common Stock Shares Outstanding | 85.2 M |
Additional Tools for Stereotaxis Stock Analysis
When running Stereotaxis' price analysis, check to measure Stereotaxis' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Stereotaxis is operating at the current time. Most of Stereotaxis' value examination focuses on studying past and present price action to predict the probability of Stereotaxis' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Stereotaxis' price. Additionally, you may evaluate how the addition of Stereotaxis to your portfolios can decrease your overall portfolio volatility.